Add-on benefits of botulinum toxin type A in combination or sequential therapies for scar management: a systematic review and meta-analysis - Scorecard - MDSpire
Advertisement
Add-on benefits of botulinum toxin type A in combination or sequential therapies for scar management: a systematic review and meta-analysis
Clinical Scorecard: Evaluating the Additional Advantages of Botulinum Toxin Type A in Combination or Sequential Treatment Approaches for Scar Management: A Systematic Review and Meta-Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Botulinum toxin type A (BoNT-A) reduces local muscle activity, decreasing mechanical tension on healing wounds. [Source needed]
Target Population
Care Setting
Key Highlights
Pooled analysis showed a Mean Difference (MD) of -1.80 for VSS and 1.46 for SBSES. [Source needed]
Guideline-Based Recommendations
Diagnosis
Management
Consider BoNT-A as an add-on therapy in multimodal scar management strategies. [Source needed]
Monitoring & Follow-up
Risks
Patient & Prescribing Data
BoNT-A may mitigate local mechanical tension and improve scar maturation. [Source needed]
Clinical Best Practices
Incorporate BoNT-A into existing scar management protocols. [Source needed]
Danish target trial emulation finds modest neuropathy benefit emerging following year 3, but high discontinuation rates complicate causal interpretation
